Artemisinin resistance-modelling the potential human and economic costs
© 2014 Lubell et al. Background: Artemisinin combination therapy is recommended as first-line treatment for falciparum malaria across the endemic world and is increasingly relied upon for treating vivax malaria where chloroquine is failing. Artemisinin resistance was first detected in western Cambod...
Saved in:
Main Authors: | Yoel Lubell, Arjen Dondorp, Philippe J. Guerin, Tom Drake, Sylvia Meek, Elizabeth Ashley, Nicholas P.J. Day, Nicholas J. White, Lisa J. White |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/34089 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Artemisinin resistance – modelling the potential human and economic costs
by: Yoel Lubell, et al.
Published: (2017) -
Artemisinin-based combinations
by: Elizabeth A. Ashley, et al.
Published: (2018) -
Ethics, economics, and the use of primaquine to reduce falciparum malaria transmission in asymptomatic populations
by: Yoel Lubell, et al.
Published: (2018) -
The last man standing is the most resistant: Eliminating artemisinin-resistant malaria in Cambodia
by: Richard J. Maude, et al.
Published: (2018) -
Artemisinin resistance: Current status and scenarios for containment
by: Arjen M. Dondorp, et al.
Published: (2018)